CGG, a global technology and HPC leader, and TGS, a global provider of energy data and intelligence, have been jointly awarded the acquisition and imaging of a dense ocean bottom node (OBN) multi-client seismic survey in the Sleipner Area of the Norwegian Continental Shelf (NCS).
CGG, a global technology and HPC leader, and TGS, a global provider of energy data and intelligence, have been jointly awarded the acquisition and imaging of a dense ocean bottom node (OBN) multi-client seismic survey in the Sleipner Area of the Norwegian Continental Shelf (NCS).
CGG, a global technology and HPC leader, and TGS, a global provider of energy data and intelligence, today announced the second phase of the Foz do Amazonas 3D multi-client survey, located in the offshore Brazil Equatorial Margin.
CGG, a global technology and HPC leader, and TGS, a global provider of energy data and intelligence, today announced the second phase of the Foz do Amazonas 3D multi-client survey, located in the offshore Brazil Equatorial Margin.
CGG has announced the start of a new Foz do Amazonas 3D seismic reimaging project, aimed at supporting Brazil’s Permanent Offer initiative in the Equatorial Margin.
CGG has announced the start of a new Foz do Amazonas 3D seismic reimaging project, aimed at supporting Brazil’s Permanent Offer initiative in the Equatorial Margin.
CGG anticipates Q4 2022 segment revenue at around $321 million, up 48% sequentially and up 8% proforma year-on-year, driven by strong aftersales, especially in the US Gulf of Mexico and Scandinavia, and higher deliveries of equipment in December 2022.
CGG anticipates Q4 2022 segment revenue at around $321 million, up 48% sequentially and up 8% proforma year-on-year, driven by strong aftersales, especially in the US Gulf of Mexico and Scandinavia, and higher deliveries of equipment in December 2022.
CGG, a global technology and HPC leader, has signed a contract to be the exclusive HPC cloud partner of Biosimulytics, an Irish pharma software company that uses artificial intelligence (AI) to dramatically improve the speed, cost, novelty and success rate in new drug development.